Schwab Charles director Paula Sneed sells $761,479 in stock

Published 30/05/2025, 00:08
Schwab Charles director Paula Sneed sells $761,479 in stock

Paula A. Sneed, a director at Schwab Charles Corp (NYSE:SCHW), a prominent $159 billion market cap financial services company with a perfect Piotroski Score according to InvestingPro, recently sold shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The transaction, dated May 27, involved the sale of 8,647 shares at a weighted average price of $88.0628, totaling approximately $761,479. This sale was executed in multiple trades at prices ranging from $87.9201 to $88.25, with the stock trading near its 52-week high and showing strong YTD returns of 19%. Following the sale, Sneed holds 105,654.1605 shares indirectly through a trust.

In addition to the sale, Sneed received a grant of 1,462 restricted stock units, which vest over three years under the company’s 2022 Stock Incentive Plan. She also acquired 3,646 nonqualified stock options, exercisable at $88.63, which will vest according to the same plan’s schedule. The company currently trades near its Fair Value, based on InvestingPro’s comprehensive analysis, which includes 8 additional key insights available to subscribers.

In other recent news, Charles Schwab Corporation has reported steady client growth in its April 2025 Monthly Activity Report. The company saw net new assets of $2.7 billion and a 12% year-over-year increase in total client assets, reaching $9.89 trillion. Additionally, Charles Schwab opened 439,000 new brokerage accounts, marking a 22% rise from April 2024. Meanwhile, the firm declared a regular quarterly cash dividend of $0.27 per common share, alongside dividends on several preferred stock series.

Analysts have also been active in updating their outlooks for Charles Schwab. TD Cowen’s Bill Katz raised the 12-month price target for the company to $113, citing a new growth phase and effective balance sheet strategies. Similarly, Goldman Sachs upgraded the stock to a Buy rating with a $100 target, highlighting robust EPS growth prospects. Keefe Bruyette & Woods also increased their price target to $93 following Charles Schwab’s earnings beat, which reported an adjusted EPS of $1.04, surpassing estimates. These developments underscore a positive sentiment among analysts regarding Charles Schwab’s financial trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.